Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 286-292, February 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrecker, A. W.
Right arrow Articles by Gallo, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrecker, A. W.
Right arrow Articles by Gallo, R. C.

Comparative Inhibition of Purified DNA Polymerases from Murine Leukemia Virus and Human Lymphocytes by 1-ß-D-Arabinofuranosylcytosine 5'-Triphosphate

Anthony W. Schrecker, R. Graham Smith and Robert C. Gallo1

Drug Research and Development [A. W. S.], and Laboratory of Tumor Cell Biology [R. G. S., R. C. G.], National Cancer Institute, NIH, Bethesda, Maryland 20014

The Km for dCTP and the K1 for 1-ß-D-arabinofuranosylcytosine 5'-triphosphate (ara-CTP) were determined with DNA polymerases purified by diethylaminoethyl cellulose and phosphocellulose chromatography from Rauscher murine leukemia virus, from human blood lymphocytes, and from a human lymphoblastoid cell line. Inhibition of the viral reverse transcriptase varied with the template/primer used. With poly(rI)·oligo(dC) (rIn·dC12-18) as the synthetic template/primer, this enzyme had a greater relative affinity for the inhibitor than had the cellular enzymes in the presence of DNA. However, when DNA was the template, inhibition of the viral enzyme was decreased considerably. DNA polymerase I of normal human lymphoid cells, which was separated from the lowermolecular-weight polymerase II and could be assayed only in the presence of DNA, had a lower relative affinity for ara-CTP than the viral reverse transcriptase directed by poly(rI)·oligo(dC). However, in the presence of magnesium ions and a DNA template, the viral enzyme was inhibited far less than either of the cellular enzymes. Since ara-CTP inhibits both viral and cellular DNA polymerases and inhibition varies with the template used, the compound cannot be considered a specific inhibitor of reverse transcriptase in studies of virus-cell interactions. The suggestion that polymerase I is involved in DNA replication is consistent with the finding that, in the presence of "activated" DNA, it is inhibited to a greater extent by ara-CTP than is polymerase II.

1 To whom reprint requests should be addressed, at Room 6N-119, Building 10, National Cancer Institute, NIH, Bethesda, Md. 20014.

Received 5/11/73. Accepted 10/25/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.